Author:
Peabody David S.,Peabody Julianne,Bradfute Steven B.,Chackerian Bryce
Abstract
Virus-like particles from a variety of RNA bacteriophages have turned out to be useful platforms for delivery of vaccine antigens in a highly immunogenic format. Here we update the current state of development of RNA phage VLPs as platforms for presentation of diverse antigens by genetic, enzymatic, and chemical display methods.
Funder
National Cancer Institute
National Institutes of Health
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine